Freshfields Bruckhaus Deringer has advised Shanghai Pharmaceuticals Holding Co. Ltd. (‘Shanghai Pharma’) on its placement of approximately 153m new H-shares on the Hong Kong Stock Exchange….
Shanghai Pharmaceuticals Holding Co. Ltd.’s US$402m H-share placement in Hong Kong
